Table 2.
Clinical test results of the participants.
| Stroke (n = 47) | Partner (n = 47) | Control (n = 34) | p | |
|---|---|---|---|---|
| WBC, ×109 | 7.09 (6.09–7.92) | 6.32 (5.22–7.45) | 6.97 (5.58–7.83) | 0.091 |
| HGB, ×109 | 141.78 ± 2.38 | 136.19 ± 2.50 | 133.79 ± 2.65 | 0.101 |
| NEU% | 62.80 (52.40–71.40) & | 58.60 (53.95–632.75) & | 62.50 (54.59–65.17) | 0.001 * |
| PLT, ×109 | 213.0 (198.0–254.0) # | 261.0 (213.5–305.5) & | 205.5 (184.0–250.0) | 0.001 * |
| UREA, μmol/L | 5.2 (4.4–5.9) | 5.0 (3.9–5.8) | 4.7 (4.1–5.8) | 0.680 |
| UA, μmol/L | 374.0 (307.0–431.0) # | 321.0 (292.0–372.0) | 357.0 (323.0–405.0) | 0.016 * |
| CR, μmol/L | 78.0 (71.0–94.0) # | 64.0 (56.5–74.0) & | 73.5 (64.0–86.0) | 0.001 * |
| Cys–C, mg/L | 1.03 ± 0.06 # | 0.81 ± 0.03 & | 1.03 ± 0.06 | 0.001 * |
| ALT, U/L | 29.02 ± 2.77 #& | 20.21 ± 2.22 | 18.55 ± 2.26 | 0.001 * |
| ALB, g/L | 44.3 (42.2–47.1) & | 44.0 (42.9–45.4) & | 39.8 (38.0–42.0) | 0.001 * |
| DBIL, μmol/L | 4.24 ± 0.24 # | 3.07 ± 0.17 & | 5.03 ± 0.56 | 0.001 * |
| TG, mmol/L | 1.22 ± 0.12 & | 1.59 ± 0.18 | 1.59 ± 0.13 | 0.025 * |
| CHOL, mmol/L | 3.56 (3.24–3.97) #& | 5.32 (4.64–6.15) | 4.74 (3.84–5.42) | 0.001 * |
| HDL–C, mmol/L | 1.19 (1.05–1.29) # | 1.44 (1.22–1.65) & | 1.15 (0.94–1.29) | 0.001 * |
| LDL–C, mmol/L | 1.96 (1.72–2.24) #& | 3.23 (2.69–3.84) | 3.09 (2.46–3.68) | 0.001 * |
| VLDL–C, mmol/L | 0.37 ± 0.02 #& | 0.67 ± 0.05 | 0.54 ± 0.05 | 0.001 * |
| FBG, ×109 | 5.73 ± 0.16 | 6.00 ± 0.34 | 5.663 ± 0.29 | 0.366 |
| HbAlc, mmol/L | 5.91 ± 0.09 & | 5.96 ± 0.16 & | 6.42 ± 0.23 | 0.010 * |
| HsCRP, mg/L | 3.41 ± 1.57 | 1.81 ± 0.40 | 1.35 ± 0.24 | 0.996 |
WBC, white blood cells; HGB, hemoglobin; NEU, neutrophils; PLT, Platelets; UA, uric acid; CR, creatinine; Cys-C, cystatin C; ALT, alanine transaminase; ALB, albumin; DBIL, direct bilirubin; TG, triglycerides; CHOL, cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; HsCRP, high-sensitivity C-reactive protein. Data are expressed as the mean ± SD. * p < 0.05, # p < 0.05 compare with the Partner group, & p < 0.05 compare with the Control group.